Clinical Trial Update: Phase III, Efficacy and Safety of "Kamada-AAT for Inhalation" [Phase 3]

View source ↗

Summary

This update reports a Phase III trial of Kamada-AAT for inhalation for Alpha-1 antitrypsin deficiency, evaluating efficacy and safety; the study is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-1 Antitrypsin Deficiency

Drugs mentioned

• Kamada-AAT for Inhalation (alpha-1 antitrypsin inhalation therapy)

Snippet

Sponsor: Kamada, Ltd. | Conditions: Alpha 1-Antitrypsin Deficiency | Phase 3 | Status: RECRUITING